BR9814549A - "composição farmacêutica contendo cloridrato de bupropion e um estabilizador" - Google Patents

"composição farmacêutica contendo cloridrato de bupropion e um estabilizador"

Info

Publication number
BR9814549A
BR9814549A BR9814549-5A BR9814549A BR9814549A BR 9814549 A BR9814549 A BR 9814549A BR 9814549 A BR9814549 A BR 9814549A BR 9814549 A BR9814549 A BR 9814549A
Authority
BR
Brazil
Prior art keywords
bupropion hydrochloride
stabilizer
pharmaceutical composition
composition containing
containing bupropion
Prior art date
Application number
BR9814549-5A
Other languages
English (en)
Inventor
Prakash Shriram Kulkarni
Bharat Bogilal Shah
Amitava Maitra
Joseph Michael Devito
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of BR9814549A publication Critical patent/BR9814549A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Abstract

Patente de Invenção: <B>"COMPOSIçãO FARMACêUTICA CONTENDO CLORIDRATO DE BUPROPION E UM ESTABILIZADOR"<D>. São providenciadas novas e estáveis formulações de cloridrato de bupropion, as quais manterão pelo menos 80% da potência do cloridrato de bupropion inicial após um ano. Métodos de inibir a degradação do cloridrato de bupropion e métodos para preparar formulações estáveis de cloridrato de bupropion também são providenciados.
BR9814549-5A 1997-12-30 1998-12-23 "composição farmacêutica contendo cloridrato de bupropion e um estabilizador" BR9814549A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/000,999 US6221917B1 (en) 1997-12-30 1997-12-30 Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
PCT/US1998/027620 WO1999033457A1 (en) 1997-12-30 1998-12-23 Pharmaceutical composition containing bupropion hydrochloride and a stabilizer

Publications (1)

Publication Number Publication Date
BR9814549A true BR9814549A (pt) 2000-10-10

Family

ID=21693907

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9814549-5A BR9814549A (pt) 1997-12-30 1998-12-23 "composição farmacêutica contendo cloridrato de bupropion e um estabilizador"

Country Status (6)

Country Link
US (3) US6221917B1 (pt)
EP (1) EP1043985A1 (pt)
AU (1) AU2015499A (pt)
BR (1) BR9814549A (pt)
CA (1) CA2316981C (pt)
WO (1) WO1999033457A1 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6153223A (en) * 1998-06-05 2000-11-28 Watson Pharmaceuticals, Inc. Stabilized pharmaceutical compositions
CN1313439C (zh) * 1998-08-07 2007-05-02 艾米斯菲尔技术有限公司 用于送递活性剂的化合物和组合物
US8545880B2 (en) * 1999-02-26 2013-10-01 Andrx Pharmaceuticals, Llc Controlled release oral dosage form
US6312716B1 (en) * 1999-05-10 2001-11-06 Peierce Management Llc Patch and method for transdermal delivery of bupropion base
US6280763B1 (en) 1999-05-10 2001-08-28 Pierce Management, Llc Apparatus and method for transdermal delivery of bupropion
US6306436B1 (en) 2000-04-28 2001-10-23 Teva Pharmaceuticals Usa, Inc. Stabilized, acid-free formulation for sustained release of bupropion hydrochloride
EP1567131A1 (en) * 2002-11-15 2005-08-31 Ranbaxy Laboratories, Ltd. Bupropion hydrochloride solid dosage forms
US6893660B2 (en) * 2002-11-21 2005-05-17 Andrx Pharmaceuticals, Inc. Stable pharmaceutical compositions without a stabilizer
CN1819821B (zh) * 2003-08-08 2010-10-13 拜奥维尔实验室国际股份有限公司 盐酸安非他酮的改良释放片剂
US20050096311A1 (en) * 2003-10-30 2005-05-05 Cns Response Compositions and methods for treatment of nervous system disorders
US8586085B2 (en) * 2004-11-08 2013-11-19 Biokey, Inc. Methods and formulations for making pharmaceutical compositions containing bupropion
US20060099262A1 (en) * 2004-11-08 2006-05-11 Biokey, Inc. Methods and formulations for making controlled release oral dosage form
KR100670798B1 (ko) 2004-12-17 2007-01-17 한국전자통신연구원 데이터베이스 캐시 시스템
US20060204571A1 (en) * 2005-03-12 2006-09-14 Sun Pharmaceutical Industries Limited Stable compositions of bupropion or its pharmaceutically acceptable salts
ZA200711123B (en) 2005-06-27 2009-08-26 Biovail Lab Int Srl Modified-release formulations of a bupropion salt
US8703191B2 (en) * 2006-07-25 2014-04-22 Intelgenx Corp. Controlled-release pharmaceutical tablets
US7674479B2 (en) * 2006-07-25 2010-03-09 Intelgenx Corp. Sustained-release bupropion and bupropion/mecamylamine tablets
ES2391912T3 (es) 2006-12-13 2012-12-03 F. Hoffmann-La Roche Ag Formulación en polvo del valganciclovir
US20110136815A1 (en) 2009-12-08 2011-06-09 Horst Zerbe Solid oral film dosage forms and methods for making same
US10610528B2 (en) 2009-12-08 2020-04-07 Intelgenx Corp. Solid oral film dosage forms and methods for making same
JP5917964B2 (ja) * 2012-03-19 2016-05-18 富士ゼロックス株式会社 錠剤、錠剤の製造方法、錠剤管理装置、錠剤照合装置及びプログラム
WO2014181280A1 (en) * 2013-05-08 2014-11-13 Genovo Development Services Limited Stable compositions of etifoxine and its salts

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759838A (fr) * 1969-12-04 1971-06-03 Wellcome Found Cetones a activite biologique
US3885046A (en) 1969-12-04 1975-05-20 Burroughs Wellcome Co Meta chloro or fluoro substituted alpha-T-butylaminopropionphenones in the treatment of depression
USRE33994E (en) 1983-08-16 1992-07-14 Burroughs Wellcome Co. Pharmaceutical delivery system
GB9217295D0 (en) 1992-08-14 1992-09-30 Wellcome Found Controlled released tablets
US5358970A (en) * 1993-08-12 1994-10-25 Burroughs Wellcome Co. Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
GB9315856D0 (en) * 1993-07-30 1993-09-15 Wellcome Found Stabilized pharmaceutical

Also Published As

Publication number Publication date
US6242496B1 (en) 2001-06-05
US6482987B2 (en) 2002-11-19
CA2316981A1 (en) 1999-07-08
US6221917B1 (en) 2001-04-24
WO1999033457A1 (en) 1999-07-08
CA2316981C (en) 2007-08-07
AU2015499A (en) 1999-07-19
EP1043985A1 (en) 2000-10-18
US20010021721A1 (en) 2001-09-13

Similar Documents

Publication Publication Date Title
BR9814549A (pt) &#34;composição farmacêutica contendo cloridrato de bupropion e um estabilizador&#34;
BR9814523A (pt) &#34;composição farmacêutica contendo cloridrato de bupropion e um estabilizador de ácido inorgânico&#34;
BR9910583A (pt) Aminotetralinas n-substituìdas como ligantes para o receptor de neuropeptìdeo y y5 úteis no tratamento de obesidade e outros distúrbios
NO960373D0 (no) Stabilisert farmasöytisk preparat inneholdende bupropion
BRPI0113286B8 (pt) pirazóis substituídos e composição farmacêutica compreendendo os mesmos.
BR9915132A (pt) Método para inibir a atividade de quinase de proteìna, compostos da fórmula i e sais farmaceuticamente aceitáveis dos mesmos, uso do mesmo, e, composição farmacêutica.
HK1135333A1 (en) Method of using diketopiperazines and composition containing them
SK157899A3 (en) Substituted pyrazoles as p38 kinase inhibitors, process for their preparation and pharmaceutical compositions
GEP20084461B (en) New derivative of 3,3- diphenyl-propylamine
EE200200486A (et) Farmatseutilised kompositsioonid, mis sisaldavad 3-aminoasetidiini derivaate, uued derivaadid ja nende valmistamismeetodid
BR9914251A (pt) Formulações orais de liberação sustentada
DE69942154D1 (de) Medikamenthaltige zusammensetzung in aerosolform
PT1401501E (pt) Composicoes farmaceuticas orais com libertacao modificada do ingrediente activo
BR9713147A (pt) Benzamidoaldeìdo, uso do mesmo, benzamida, e, preparação medicamentosa para administração oral, parenteral ou intraperitoneal.
HK1043365B (zh) N-(亞氨基甲基)胺衍生物，其製備方法，其作為藥物的用途以及含有該化合物的藥物組合物
ATE231872T1 (de) Thiazolopyrimidinderivate
BR0008228A (pt) Composições de n-benzoil estaurosporinaespontaneamente dispersìveis
NO304113B1 (no) Krystallinsk tiagabinhydrokloridmonohydrat, farmas°ytisk preparat som omfatter det, og anvendelse derav for fremstilling av et medikament
RS11304A (en) Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation
TW200420557A (en) Salt of 7-isoindoline-quinolonecarboxylic acid derivative, its hydrate and anti-bacterially pharmaceutical composition comprising the same as active ingredient
HUP0103530A3 (en) N,n-substituted cyclic amine derivatives and pharmaceutical compositions containing them
SE9802937D0 (sv) Novel compounds
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
BR0114395A (pt) Composição farmacêutica para administração por suprimento via oral
ES2192789T3 (es) Derivados de hidrazono-benzazuleno, composiciones farmaceuticas y compuestos intermedios.

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: WYETH (US)

Free format text: ALTERADO DE: AMERICAN HOME PRODUCTS CORPORATION

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFARENTE A 7O E 8O ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1910 DE 14/08/2007.